Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001410578-24-001438
Filing Date
2024-08-14
Accepted
2024-08-14 16:06:56
Documents
17
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A rytm-20240630x10qa.htm   iXBRL 10-Q/A 83876
2 EX-31.1 rytm-20240630xex31d1.htm EX-31.1 4072
3 EX-31.2 rytm-20240630xex31d2.htm EX-31.2 3810
  Complete submission text file 0001410578-24-001438.txt   425238

Data Files

Seq Description Document Type Size
4 EX-101.SCH rytm-20240630.xsd EX-101.SCH 5308
5 EX-101.DEF rytm-20240630_def.xml EX-101.DEF 38696
6 EX-101.LAB rytm-20240630_lab.xml EX-101.LAB 24537
7 EX-101.PRE rytm-20240630_pre.xml EX-101.PRE 15837
20 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20240630x10qa_htm.xml XML 19788
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38223 | Film No.: 241207610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)